🚀 VC round data is live in beta, check it out!

Cencora Valuation Multiples

Discover revenue and EBITDA valuation multiples for Cencora and similar public comparables like Rheinmetall, Grainger, Cardinal Health, Fastenal and more.

Cencora Overview

About Cencora

Cencora is one of three leading domestic pharmaceutical wholesalers. It sources and distributes branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. It and McKesson and Cardinal Health hold over 90% share of the US pharmaceutical wholesale industry. Cencora also provides commercialization services for manufacturers of pharmaceuticals and medical devices, global specialty drug logistics (World Courier), and animal health product distribution (MWI Animal Health). Cencora expanded its international presence in 2021 by purchasing Alliance Healthcare, one of the leading drug wholesalers in Europe.


Founded

2001

HQ

United States

Employees

51.0K

Financials (LTM)

Revenue: $333B
EBITDA: $5B

EV

$76B

Valuation Multiples

Multiples.vc

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Cencora Financials

Cencora reported last 12-month revenue of $333B and EBITDA of $5B.

In the same LTM period, Cencora generated $12B in gross profit, $5B in EBITDA, and $3B in net income.

Revenue (LTM)


Cencora P&L

In the most recent fiscal year, Cencora reported revenue of $321B and EBITDA of $5B.

Cencora expects next 12-month revenue of XXX and NTM EBITDA of XXX

See Cencora forward-looking valuation multiples
LTMNTMLast FYFY 2026FY 2027FY 2028
Revenue$333BXXX$321BXXXXXXXXX
Gross Profit$12BXXX$11BXXXXXXXXX
Gross Margin4%XXX4%XXXXXXXXX
EBITDA$5BXXX$5BXXXXXXXXX
EBITDA Margin2%XXX2%XXXXXXXXX
EBIT Margin1%XXX1%XXXXXXXXX
Net Profit$3BXXX$3BXXXXXXXXX
Net Margin1%XXX1%XXXXXXXXX
Net Debt——$3BXXXXXXXXX

Financial data powered by Morningstar, Inc.

Cencora Stock Performance

Cencora has current market cap of $72B, and enterprise value of $76B.

Market Cap Evolution


Cencora's stock price is $372.65.

See Cencora trading valuation data
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$76B$72B0.0%XXXXXXXXX$16.05

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Cencora Valuation Multiples

Cencora trades at 0.2x EV/Revenue multiple, and 15.2x EV/EBITDA.

See valuation multiples for Cencora and 15K+ public comps

EV / Revenue (LTM)


Cencora Financial Valuation Multiples

As of March 17, 2026, Cencora has market cap of $72B and EV of $76B.

Equity research analysts estimate Cencora's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

Cencora has a P/E ratio of 22.2x.

LTMNTMLast FYFY 2026FY 2027FY 2028
Market cap (current)$72BXXX$72BXXXXXXXXX
EV (current)$76BXXX$76BXXXXXXXXX
EV/Revenue0.2xXXX0.2xXXXXXXXXX
EV/EBITDA15.2xXXX16.1xXXXXXXXXX
EV/EBIT17.0xXXX17.9xXXXXXXXXX
EV/Gross Profit6.4xXXX6.6xXXXXXXXXX
P/E22.2xXXX23.2xXXXXXXXXX
EV/FCF25.5xXXX23.6xXXXXXXXXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Cencora Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Cencora Margins & Growth Rates

Cencora's revenue in the last 12 month grew by 7%.

Cencora's revenue per employee in the last FY averaged $6.5M.

Cencora's rule of 40 is 9% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Cencora's rule of X is 20% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

See operational valuation multiples for Cencora and other 15K+ public comps

Cencora Operational Valuation Multiples

LTMNTMLast FYFY 2026FY 2027FY 2028
Revenue Growth7%XXX8%XXXXXXXXX
EBITDA Margin2%XXX2%XXXXXXXXX
EBITDA Growth11%XXX13%XXXXXXXXX
Rule of 40—XXX9%XXXXXXXXX
Bessemer Rule of X—XXX20%XXXXXXXXX
Revenue per Employee—XXX$6.5MXXXXXXXXX
Opex to Revenue—XXX2%XXXXXXXXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Cencora Public Comps

See public comps and valuation multiples for other Wholesale Distribution comps.

EV/RevenueEV/EBITDA
LTM2026E2027ELTM2026E2027E
RheinmetallXXXXXXXXXXXXXXXXXX
GraingerXXXXXXXXXXXXXXXXXX
Cardinal HealthXXXXXXXXXXXXXXXXXX
FastenalXXXXXXXXXXXXXXXXXX
FergusonXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXXXXXXX

Valuation data powered by FactSet, Inc.

Cencora M&A Activity

Cencora acquired XXX companies to date.

Last acquisition by Cencora was on XXXXXXXX, XXXXX. Cencora acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).

See M&A valuation multiples

Latest Acquisitions by Cencora

Acquired CompanyValuationEV/RevenueEV/EBITDA
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX

Get Verified M&A Valuation Multiples

Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.

Start Free Trial

Cencora Investment Activity

Cencora invested in XXX companies to date.

Cencora made its latest investment on XXXXXXXX, XXXXX. Cencora invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).

See VC round multiples

Latest Investments by Cencora

CompanyValuationEV/RevenueEV/EBITDA
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Cencora

When was Cencora founded?Cencora was founded in 2001.
Where is Cencora headquartered?Cencora is headquartered in United States.
How many employees does Cencora have?As of today, Cencora has over 51K employees.
Who is the CEO of Cencora?Cencora's CEO is Robert P. Mauch.
Is Cencora publicly listed?Yes, Cencora is a public company listed on NYSE.
What is the stock symbol of Cencora?Cencora trades under COR ticker.
When did Cencora go public?Cencora went public in 1995.
Who are competitors of Cencora?Cencora main competitors are Rheinmetall, Grainger, Cardinal Health, Fastenal.
What is the current market cap of Cencora?Cencora's current market cap is $72B.
What is the current revenue of Cencora?Cencora's last 12 months revenue is $333B.
What is the current revenue growth of Cencora?Cencora revenue growth (NTM/LTM) is 7%.
What is the current EV/Revenue multiple of Cencora?Current revenue multiple of Cencora is 0.2x.
Is Cencora profitable?Yes, Cencora is EBITDA-positive (as of the last 12 months).
What is the current EBITDA of Cencora?Cencora's last 12 months EBITDA is $5B.
What is Cencora's EBITDA margin?Cencora's last 12 months EBITDA margin is 2%.
What is the current EV/EBITDA multiple of Cencora?Current EBITDA multiple of Cencora is 15.2x.
What is the current FCF of Cencora?Cencora's last 12 months FCF is $3B.
What is Cencora's FCF margin?Cencora's last 12 months FCF margin is 1%.
What is the current EV/FCF multiple of Cencora?Current FCF multiple of Cencora is 25.5x.

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial